Skip to main content
. 2022 Oct 31;24(2):e13827. doi: 10.1002/acm2.13827

TABLE 1.

Patients’ characteristics

Pt. # Age (year) Sex Primary site Stage TNM (UICC 8th) GTV size (cm3) CTV size (cm3) PTV size (cm3) Overlap ratio (%)
1 72 M Body BR T4N0M0 12.3 94.9 173.1 10.7
2 59 F Body BR T4N1M0 111.6 217.5 348.1 18.5
3 71 M Head BR T4N0M0 38.1 144.3 249.2 15.2
4 79 M Head UR T4N0M0 13.7 101.2 198.9 12.7
5 57 M Body UR T4N0M0 87.3 203.0 330.7 8.9
6 71 F Head BR T2N0M0 31.3 119.1 119.1 16.7
8 78 M Head BR T2N0M0 5.3 104.2 190.9 6.9
9 78 M Body BR T4N0M0 17.9 103.2 187.3 11.5
10 69 M Body BR T2N0M0 18.2 133.7 236.2 15.2
11 64 F Head BR T4N0M0 28.1 91.6 184.8 15.6
12 62 F Head UR T4N0M0 89.8 184.0 297.7 11.6

Note: Patient 7 was excluded from this study because daily CBCT, which was performed with a lower mAs value for the patient's body shape, was not available at the segmentation stage due to extremely poor image quality. Overlap refers to the area where the PTV and PRV overlap. The overlap ratio was calculated as the overlap volume to the PTV volume.

Abbreviations: BR, borderline resectable; CBCT, cone‐beam computed tomography; CTV, clinical target volume; GTV, gross tumor volume; PRV, planning organs at risk volume; PTV, planning target volume; UR, unresectable.